(Q46537963)

English

Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

scientific article published in April 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/7709971

Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/7709971

Cytomegalovirus

0 references

cytomegalovirus retinitis

1 reference

based on heuristic

inferred from title

author name string

L S Kirsch

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/7709971

J F Arevalo

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/7709971

E De Clercq

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/7709971

E Chavez de la Paz

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/7709971

D Munguia

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/7709971

R Garcia

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/7709971

W R Freeman

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/7709971

language of work or name

0 references

publication date

1 April 1995

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/7709971

American Journal of Ophthalmology

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/7709971

119

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/7709971

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/7709971

466-476

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/7709971

Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Ophthalmic Involvement in Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Progression rates of cytomegalovirus retinopathy in ganciclovir-treated and untreated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Long-term visual morbidity of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Acquired immune deficiency syndrome. Ocular manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Ocular manifestations of acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Cytomegalovirus retinitis and acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

A novel selective broad-spectrum anti-DNA virus agent

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) against guinea pig cytomegalovirus infection in cultured cells and in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Comparative activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against rat cytomegalovirus infection in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for the treatment of murine cytomegalovirus infection in severe combined immunodeficiency mice

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Treatment of murine cytomegalovirus infections in severe combined immunodeficient mice with ganciclovir, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, interferon, and bropirimine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Evaluation of HPMPC therapy for primary and recurrent genital herpes in mice and guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Long-acting therapy of viral retinitis with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Useful adjuncts for vitreoretinal surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Mechanism of inhibition of adenovirus DNA replication by the acyclic nucleoside triphosphate analogue (S)-HPMPApp: influence of the adenovirus DNA binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Treatment of cytomegalovirus retinopathy in patients with acquired immunodeficiency syndrome. Use of the experimental drug 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Treatment of cytomegalovirus retinitis with ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Intravenous and intraocular ganciclovir for CMV retinitis in patients with AIDS or chemotherapeutic immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

A Randomized, Controlled Trial of Foscarnet in the Treatment of Cytomegalovirus Retinitis in Patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Combination ganciclovir and foscarnet in the treatment of clinically resistant cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971233-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9394(14)71233-4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/7709971

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/7709971

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46537963&oldid=2116933807"